Judge rules Jazz Pharma did not lie to get lower patent fees for Epidiolex
A federal judge found that the producer of the only medical-grade CBD product approved by the U.S. Food & Drug Administration (FDA) did not lie to the U.S. Patent and […]
Judge rules Jazz Pharma did not lie to get lower patent fees for Epidiolex Read More »